# Drug Use and Addiction Research Programs (93.279)

Source: https://welltoldgrants.com/programs/93-279-drug-use-and-addiction-research-programs/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Drug Use and Addiction Research Programs is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $7.3 billion in 5,071 grants, about $1.4 million per award.

## Objectives

To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. To support research training and research scientist development. To support dissemination of research findings.
Small Business Innovation Research (SBIR) legislation is intended to expand and improve the SBIR programs to emphasize and increase private sector commercialization of technology developed through Federal SBIR research and development; increase small business participation in Federal research and development; and foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in the SBIR program. The Small Business Technology Transfer (STTR) legistlation is intended to stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; foster technology transfer between small business concerns and research institutions; increase private sector commercialization of innovations derived from Federal research and development; and foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $1.4 billion | 2,158 |
| 2022 | $1.5 billion | 2,354 |
| 2023 | $1.5 billion | 2,409 |
| 2024 | $1.5 billion | 2,459 |
| 2025 | $1.5 billion | 2,337 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| Yale Univ | Connecticut | $305 million |
| The Johns Hopkins University | Maryland | $262 million |
| University of California, San Diego | California | $242 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | $182 million |
| New York University | New York | $173 million |
| Regents of the University of Michigan | Michigan | $144 million |
| University of Washington | Washington | $143 million |
| Icahn School of Medicine at Mount Sinai | New York | $120 million |
| The Washington University | Missouri | $119 million |
| The General Hospital Corporation | Massachusetts | $116 million |
| University of California, Los Angeles | California | $116 million |
| The Regents of the University of California, San Francisco | California | $115 million |
| The Leland Stanford Junior University | California | $113 million |
| The University of Kentucky Research Foundation | Kentucky | $110 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | $99.5 million |
| University of North Carolina at Chapel Hill | North Carolina | $89.4 million |
| Duke University | North Carolina | $86.8 million |
| Research Triangle Institute | North Carolina | $86.7 million |
| University of Florida | Florida | $85.7 million |
| Regents of the University of Minnesota | Minnesota | $85.3 million |

## Open opportunities

- [NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-24-089-nida-mentored-clinical-scientist-development-program-award/), closes November 13, 2026
- [Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-370-ethical-legal-and-social-implications-elsi-small-research/), closes November 16, 2026
- [Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-369-ethical-legal-and-social-implications-elsi-exploratory/), closes November 18, 2026
- [Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-371-ethical-legal-and-social-implications-elsi-research-r01/), closes November 18, 2026
- [Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-23-317-competing-revisions-to-existing-nih-single-project-research/), closes November 24, 2026
- [Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-296-emerging-global-leader-award-k43-independent-clinical-trial/), closes December 3, 2026
- [Emerging Global Leader Award (K43 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/par-24-295-emerging-global-leader-award-k43-independent-clinical-trial/), closes December 3, 2026
- [NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-od-24-011-nih-research-software-engineer-rse-award-r50-clinical/), closes December 4, 2026
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)](https://welltoldgrants.com/grants/par-24-214-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2027
- [Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-378-intervention-research-to-improve-native-american-health-r34/), closes January 7, 2027
- [Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-379-intervention-research-to-improve-native-american-health-r01/), closes January 7, 2027
- [HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-da-28-011-heal-initiative-integrative-management-of-chronic-pain-and/), closes January 26, 2027
- [HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-28-012-heal-initiative-integrative-management-of-chronic-pain-and/), closes January 26, 2027
- [Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-268-biomedical-research-environment-and-sponsored-programs/), closes January 27, 2027
- [BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-24-031-brain-initiative-preclinical-proof-of-concept-for-novel/), closes January 28, 2027
- [BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-mh-26-170-brain-initiative-development-and-validation-of-novel-tools/), closes February 8, 2027
- [Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-28-013-neural-ensembles-used-substances-nexus-collaboratory/), closes February 8, 2027
- [NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-269-nida-animal-genomics-program-u01-clinical-trial-not/), closes February 11, 2027
- [BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-dc-27-004-brain-initiative-exploratory-research-opportunities-using/), closes February 11, 2027
- [NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-lm-28-001-nlm-institutional-grants-for-research-training-in-biomedical/), closes February 11, 2027
- [High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-da-25-060-high-priority-hiv-and-substance-use-research-rm1/), closes March 5, 2027
- [Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-081-discovery-of-in-vivo-chemical-probes-for-the/), closes March 5, 2027
- [High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-da-25-024-high-priority-hiv-and-substance-use-research-r01/), closes March 6, 2027
- [NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-100-nih-cdc-and-fda-small-business-innovation-research/), closes April 5, 2027
- [NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-102-nih-small-business-technology-transfer-grant-parent-sttr/), closes April 5, 2027
- [Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-od-25-003-short-courses-on-innovative-methodologies-and-approaches-in/), closes April 9, 2027
- [Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-201-emergency-competitive-revision-to-existing-nih-awards/), closes April 18, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-185-mentored-patient-oriented-research-career-development-award/), closes May 7, 2027
- [Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-190-mentored-quantitative-research-development-award-parent-k25/), closes May 7, 2027
- [Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-191-mentored-quantitative-research-development-award-parent-k25/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-175-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-176-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-178-independent-scientist-award-parent-k02-independent-clinical/), closes May 7, 2027
- [Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-179-independent-scientist-award-parent-k02-independent-clinical/), closes May 7, 2027
- [NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-194-nih-pathway-to-independence-award-parent-k99-r00/), closes May 7, 2027
- [NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-193-nih-pathway-to-independence-award-parent-k99-r00/), closes May 7, 2027
- [Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-187-midcareer-investigator-award-in-patient-oriented-research/), closes May 7, 2027
- [Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-188-midcareer-investigator-award-in-patient-oriented-research/), closes May 7, 2027
- [Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)](https://welltoldgrants.com/grants/par-26-001-screening-brief-intervention-and-referral-to-treatment-or/), closes May 7, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-184-mentored-patient-oriented-research-career-development-award/), closes May 8, 2027
- [Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-181-mentored-clinical-scientist-research-career-development/), closes May 8, 2027
- [Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-182-mentored-clinical-scientist-research-career-development/), closes May 8, 2027
- [BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-mh-26-120-brain-initiative-reagent-resources-for-brain-cell-type/), closes June 15, 2027
- [Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-254-change-of-recipient-organization-type-7-parent-clinical/), closes July 12, 2027
- [Successor-in-Interest (Type 6 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-253-successor-in-interest-type-6-parent-clinical-trial/), closes July 17, 2027
- [Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-101-cutting-edge-basic-research-awards-cebra-r21-clinical/), closes August 11, 2027
- [Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-24-293-blueprint-neurotherapeutics-network-bpn-biologic-based-drug/), closes August 18, 2027
- [NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-080-nih-support-for-conferences-and-scientific-meetings-parent/), closes September 7, 2027
- [BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-27-015-brain-initiative-connectivity-across-scales-brain-connects/), closes October 4, 2027
- [Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)](https://welltoldgrants.com/grants/par-27-078-research-enhancement-award-program-reap-for-health/), closes October 25, 2027
- [Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-100-pilot-health-services-and-economic-research-on-the/), closes October 27, 2027
- [Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-mh-27-125-mechanistic-evaluation-of-therapeutic-targets-derived-from/), closes October 28, 2027
- [BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-27-004-brain-initiative-theories-models-and-methods-for-analysis/), closes November 8, 2027
- [Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-26-034-chemical-countermeasures-research-program-ccrp-initiative/), closes November 18, 2027
- [Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-26-055-accelerating-the-pace-of-substance-use-research-using/), closes December 3, 2027
- [Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-26-056-accelerating-the-pace-of-substance-use-research-using/), closes December 3, 2027
- [Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-144-dissemination-and-implementation-research-in-health-r01/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-233-dissemination-and-implementation-research-in-health-r03/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-143-dissemination-and-implementation-research-in-health-r21/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-148-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)](https://welltoldgrants.com/grants/par-25-292-the-role-of-work-in-health-disparities-in/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-134-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-298-research-enhancement-award-program-reap-for-health/), closes January 7, 2028
- [NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-302-nih-small-research-grant-program-parent-r03-clinical/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-304-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)](https://welltoldgrants.com/grants/pa-25-306-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-301-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Required)](https://welltoldgrants.com/grants/pa-25-305-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-383-blueprint-medtech-translator-ug3-uh3-clinical-trial-optional/), closes January 28, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)](https://welltoldgrants.com/grants/pa-25-168-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 4, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)](https://welltoldgrants.com/grants/pa-25-423-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-425-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-426-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)](https://welltoldgrants.com/grants/pa-25-424-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)](https://welltoldgrants.com/grants/pa-25-422-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-053-exploratory-clinical-neuroscience-research-on-substance-use/), closes June 16, 2028
- [BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-27-002-brain-initiative-integrative-team-research-brain-circuits/), closes June 23, 2028
- [Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-446-development-of-interventions-to-prevent-and-treat-substance/), closes August 21, 2028
- [Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-414-support-for-research-excellence-sure-award-r16-clinical/), closes September 7, 2028
- [Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-415-support-for-research-excellence-first-independent-research/), closes September 7, 2028
- [Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-026-avant-garde-avenir-awards-for-investigators-conducting-high/), closes September 25, 2028
- [Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ai-27-014-development-of-candidate-medical-countermeasures-mcms-and/), closes October 9, 2028
- [CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-075-ccrp-initiative-promoting-a-basic-understanding-of-chemical/), closes November 5, 2028
- [Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-001-administrative-supplements-to-existing-nih-grants-and/), closes November 30, 2028
- [BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-28-010-brain-initiative-research-opportunities-using-invasive/), closes February 8, 2029
- [HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-da-27-016-heal-initiative-translating-addiction-epidemiology/), closes February 9, 2029
- [HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ns-27-007-heal-initiative-non-addictive-analgesic-therapeutics/), closes February 20, 2029
- [Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)](https://welltoldgrants.com/grants/pas-27-028-science-track-award-for-research-transition-start-program/), closes March 16, 2029
- [Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-037-predoctoral-to-postdoctoral-transition-award-parent-f99-k00/), closes April 8, 2029
- [NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-051-nih-brain-development-cohorts-nbdc-and-population-assessment/), closes April 17, 2029
- [NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-036-nih-research-education-program-research-experiences-parent/), closes May 5, 2029
- [NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-035-nih-research-educational-program-mentoring-activities/), closes May 5, 2029
- [NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-002-nih-collaborative-international-research-project-parent-pf5/), closes May 7, 2029
- [NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-077-nih-science-education-partnership-award-sepa-r25-clinical/), closes May 25, 2029
- [NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-034-nih-research-education-program-courses-curriculum-methods/), closes May 25, 2029
- [Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-28-090-centers-for-aids-research-cfar-and-developmental-centers/), closes May 25, 2029
- [NIH Research Program Projects (Parent P01 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-061-nih-research-program-projects-parent-p01-clinical-trial/), closes May 25, 2029
- [Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ai-27-018-implementation-science-to-advance-hiv-prevention-treatment/), closes June 20, 2029
- [Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/pa-27-030-institutional-mentored-career-development-award-parent-k12/), closes July 12, 2029
- [Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-28-093-pilot-and-feasibility-studies-in-preparation-for-substance/), closes July 16, 2029
- [Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-003-collaborative-program-grant-for-interdisciplinary-teams-rm1/), closes September 26, 2029
- [NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-eb-28-004-nexttech-translational-development-of-next-generation/), closes December 1, 2030
- [NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System](https://welltoldgrants.com/grants/rfa-da-27-012-nih-blueprint-initiative-tools-for-germline-gene-editing/), closes not stated
- [Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-039-small-business-transition-grant-for-new-entrepreneurs-parent/), closes not stated
- [Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-040-small-business-transition-grant-for-new-entrepreneurs-parent/), closes not stated
- [NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science](https://welltoldgrants.com/grants/rfa-da-28-002-nida-avenir-program-fundamental-mechanistic-research-in/), closes not stated
- [Implementation and Evaluation of Databases to Examine AIDS](https://welltoldgrants.com/grants/rfa-ai-28-025-implementation-and-evaluation-of-databases-to-examine-aids/), closes not stated
- [Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2](https://welltoldgrants.com/grants/rfa-da-28-001-single-cell-opioid-responses-in-the-context-of/), closes not stated
- [Intervention Research to Improve Native American Health](https://welltoldgrants.com/grants/par-28-016-intervention-research-to-improve-native-american-health/), closes not stated